Miles Marchand presented the SODIUM-HF Trial which was an international, open-label, randomised, controlled trial comparing usual care according to local guidelines or a low sodium diet of less than 100 mmol (ie, <1500 mg/day) among patients…
Read More
Dr. Charmaine Lam will presented the EMPEROR-Preserved Trial, which is a double-blind, randomized control trial comparing the use of empagliflozin (10mg) to placebo among patients with class II–IV heart failure…
Read More